Why the study?
Does verapamil 120 mg thrice daily improve anginal threshold and ischemic ST segment changes during exercise in patients with ischemic heart disease?
Population
25 patients with ischaemic heart disease (including 13 symptomatic patients)
Comparison
Verapamil 120 mg thrice daily for 8 weeks vs Baseline assessment without any drugs, and…
Design
Cohort
Follow-up
8 weeks
Authors
Loading...
May support verapamil in angina; hypothesis-generating from small cohort and requires RCT confirmation.
Does verapamil 120 mg thrice daily improve anginal threshold and ischemic ST segment changes during exercise in patients with ischemic heart disease?
Verapamil 360 mg/day is an effective and well-tolerated antianginal agent that improves exercise-induced ischemia and anginal threshold in patients with ischemic heart disease.
Balasubramanian et al. (1976) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: